variou
measur
avail
inactiv
remov
virus
manufactur
product
present
studi
evalu
abil
liquid
heat
treatment
inactiv
coronaviru
cov
associ
sever
acut
respiratori
syndrom
sar
viru
introduc
sever
product
manufactur
process
immedi
liquid
heat
treatment
use
vero
cell
cultur
minim
essenti
medium
mem
contain
fetal
bovin
serum
fb
uml
penicillin
streptomycin
propag
strain
strain
kindli
provid
dr
john
ziebuhr
univers
germani
dr
fumihiro
taguchi
nation
institut
infecti
diseas
tokyo
japan
infect
assay
vero
cell
seed
micropl
cellsml
mlwell
overnight
cultur
cell
inocul
serial
dilut
viru
stock
solut
mlwell
five
well
per
dilut
day
cultur
viru
infect
tissu
cultur
infect
dose
calcul
use
karber
method
four
product
test
suppli
benesi
corpor
osaka
japan
glycol
peg
intraven
immunoglobulin
prepar
kenketsu
iii
prepar
haptoglobin
prepar
haptoglobin
human
serum
albumin
prepar
kenketsu
sampl
product
use
studi
collect
immedi
liquid
heat
treatment
use
manufactur
sampl
inocul
follow
heat
treatment
liquid
h
remain
infect
titrat
describ
four
sampl
rapidli
inactiv
detect
limit
within
min
howev
infect
iii
prepar
persist
despit
heat
min
although
amount
heat
inactiv
viru
three
prepar
fig
result
confirm
independ
experi
data
shown
furthermor
inocul
solut
contain
stabil
alon
without
protein
min
heat
inactiv
viru
detect
limit
four
product
data
shown
suggest
combin
blood
product
prepar
stabil
affect
heat
sensit
viru
rabenau
colleagu
also
conduct
experi
use
strain
studi
found
viru
stabil
heat
min
presenc
fb
inactiv
presenc
absenc
fb
context
therefor
must
take
consider
combin
plasma
product
stabil
